---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-104294"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2023-09-27T23:59:59+00:00"
generated_at: "2026-06-10T08:17:26.593951+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Anzu SPAC shareholders approve merger with Envoy Medical; close expected Sept 29

## Summary
- Over 99% of votes cast at Sept 27 special meeting favored the business combination.
- All seven other proposals also approved, including charter amendments and director elections.
- Closing expected Sept 29, 2023; post-closing name changes to Envoy Medical, Inc.
- New trading symbols: COCH for Class A Common Stock, COCHW for warrants on Nasdaq.
- Extension meeting cancelled since deal closing before Sept 30 deadline.

## SEC filing metadata
- accession: 0001104659-23-104294
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2023-09-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000110465923104294/0001104659-23-104294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000110465923104294/tm2327084d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-104294
- JSON: https://secwatch.observer/filing/0001104659-23-104294.json
- Plain text: https://secwatch.observer/filing/0001104659-23-104294.txt

## Key facts
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved The Business Combination Proposal - approval of the Business Combination Agreement and the Business Combination at the 2023-09-27 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2023-09-27
  source text: The Business Combination Proposal was approved by the Company’s stockholders, and received the following votes: Class of Common Stock For Against Abstain Class A Common Stock and Class B Common Stock, voting as a single class 13,116,546 17,543 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465923104294/0001104659-23-104294-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Advisory Charter Proposals - six non-binding governance proposals at the 2023-09-27 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-09-27
  source text: Each of the Advisory Charter Proposals was approved. The votes for each sub-proposal were as follows: A. To change the total number of shares of all classes of authorized capital stock of the Company from 441,000,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465923104294/0001104659-23-104294-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved The Charter Proposal - approval of the Second Amended and Restated Certificate of Incorporation of New Envoy at the 2023-09-27 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-09-27
  source text: The Charter Proposal was approved by the Company’s stockholders, and received the following votes: Class of Common Stock For Against Abstain Class A Common Stock and Class B Common Stock, voting as a single class 12,845,753 288,246 0 Class A Common Stock, voting as a separate class 2,270,753 288,246 0 Class B Common Stock, voting as a separate class 10,575,000 0 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465923104294/0001104659-23-104294-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.